These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24521008)

  • 21. New insights on therapy with vitamin D analogs targeting the intracellular pathways that control repigmentation in human vitiligo.
    Birlea SA; Costin GE; Norris DA
    Med Res Rev; 2009 May; 29(3):514-46. PubMed ID: 19241402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repigmentation in vitiligo: position paper of the Vitiligo Global Issues Consensus Conference.
    Gan EY; Eleftheriadou V; Esmat S; Hamzavi I; Passeron T; Böhm M; Anbar T; Goh BK; Lan CE; Lui H; Ramam M; Raboobee N; Katayama I; Suzuki T; Parsad D; Seth V; Lim HW; van Geel N; Mulekar S; Harris J; Wittal R; Benzekri L; Gauthier Y; Kumarasinghe P; Thng ST; Silva de Castro CC; Abdallah M; Vrijman C; Bekkenk M; Seneschal J; Pandya AG; Ezzedine K; Picardo M; Taïeb A;
    Pigment Cell Melanoma Res; 2017 Jan; 30(1):28-40. PubMed ID: 27864868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitiligo surgical, laser, and alternative therapies: a review and case series.
    Wassef C; Lombardi A; Khokher S; Rao BK
    J Drugs Dermatol; 2013 Jun; 12(6):685-91. PubMed ID: 23839187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
    Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on skin repigmentation therapies in vitiligo.
    Falabella R; Barona MI
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):42-65. PubMed ID: 19040503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-cultured melanocyte-keratinocyte transplantation for the treatment of vitiligo: a clinical trial in an Iranian population.
    Toossi P; Shahidi-Dadras M; Mahmoudi Rad M; Fesharaki RJ
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1182-6. PubMed ID: 21214632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrathin split-thickness skin grafting followed by narrowband UVB therapy for stable vitiligo: an effective and cosmetically satisfying treatment option.
    Majid I; Imran S
    Indian J Dermatol Venereol Leprol; 2012; 78(2):159-64. PubMed ID: 22421646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of nonsegmental childhood vitiligo: a randomized placebo-controlled study.
    Farajzadeh S; Daraei Z; Esfandiarpour I; Hosseini SH
    Pediatr Dermatol; 2009; 26(3):286-91. PubMed ID: 19706089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitiligo patients seeking depigmentation therapy: a case report and guidelines for psychological screening.
    Grau C; Silverberg NB
    Cutis; 2013 May; 91(5):248-52. PubMed ID: 23772431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients.
    Linthorst Homan MW; Spuls PI; Nieuweboer-Krobotova L; de Korte J; Sprangers MA; Bos JD; Wolkerstorfer A; van der Veen JP
    J Eur Acad Dermatol Venereol; 2012 Jun; 26(6):690-5. PubMed ID: 21711467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of vitiligo with a melanocyte-keratinocyte cell suspension versus dermabrasion only: a pilot study with a 12-month follow up.
    Vázquez-Martínez OT; Martínez-Rodríguez HG; Velásquez-Arenas L; Baños-González D; Ortíz-López R; Padilla-Rivas G; Welsh O; Ocampo-Candiani J
    J Drugs Dermatol; 2011 Sep; 10(9):1032-6. PubMed ID: 22052273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Satellite repigmentation after punch grafting.
    Agarwal US; Gulati R; Shukla SR; Mathur N
    Int J Dermatol; 2004 Apr; 43(4):273-4. PubMed ID: 15090010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Independent component analysis for assessing therapeutic response in vitiligo skin disorder.
    Fadzil MH; Norashikin S; Suraiya HH; Nugroho H
    J Med Eng Technol; 2009; 33(2):101-9. PubMed ID: 19205989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraepidermal injection of dissociated epidermal cell suspension improves vitiligo.
    Khodadadi L; Shafieyan S; Sotoudeh M; Dizaj AV; Shahverdi A; Aghdami N; Baharvand H
    Arch Dermatol Res; 2010 Oct; 302(8):593-9. PubMed ID: 20364383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical treatment and combination approaches for vitiligo: new insights, new developments.
    Hossani-Madani AR; Halder RM
    G Ital Dermatol Venereol; 2010 Feb; 145(1):57-78. PubMed ID: 20197746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue-engineered skin in the treatment of vitiligo lesions.
    Arenberger P; Broz L; Veselý P; Havlícková B; Matousková E
    Folia Biol (Praha); 2000; 46(4):157-60. PubMed ID: 10954161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depigmentation therapy in vitiligo universalis with cryotherapy and 4-hydroxyanisole.
    Di Nuzzo S; Masotti A
    Clin Exp Dermatol; 2010 Mar; 35(2):215-6. PubMed ID: 20447090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitiligo therapy: where are we now?
    Arroyo MP; Tift L
    J Drugs Dermatol; 2003 Aug; 2(4):404-8. PubMed ID: 12884463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitiligo--the loss of pigmentation in skin patches.
    Marrs R
    Prof Nurse; 1990 Jun; 5(9):470-1. PubMed ID: 2367540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of vitiligo.
    Taneja A
    J Dermatolog Treat; 2002 Mar; 13(1):19-25. PubMed ID: 12006134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.